Alignment Healthcare (NASDAQ:ALHC) Insider Hyong Kim Sells 51,379 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 51,379 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, October 9th. The shares were sold at an average price of $17.57, for a total transaction of $902,729.03. Following the sale, the insider directly owned 362,333 shares in the company, valued at $6,366,190.81. This trade represents a 12.42% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Hyong Kim also recently made the following trade(s):

• On Wednesday, October 8th, Hyong Kim sold 33,655 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.29, for a total transaction of $581,894.95.
• On Friday, August 22nd, Hyong Kim sold 24,800 shares of Alignment Healthcare stock. The shares were sold at an average price of $16.00, for a total transaction of $396,800.00.
• On Monday, August 11th, Hyong Kim sold 18,600 shares of Alignment Healthcare stock. The shares were sold at an average price of $14.54, for a total transaction of $270,444.00.

Alignment Healthcare Trading Down 1.4%

Shares of Alignment Healthcare stock opened at $17.31 on Friday. The firm has a market capitalization of $3.43 billion, a PE ratio of -61.82 and a beta of 1.18. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. The firm’s 50 day moving average is $16.06 and its 200 day moving average is $15.67. Alignment Healthcare, Inc. has a 1 year low of $10.11 and a 1 year high of $21.06.

Alignment Healthcare (NASDAQ:ALHC) last posted its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. During the same period in the previous year, the firm posted ($0.13) EPS. The company’s revenue for the quarter was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday. Barclays upgraded shares of Alignment Healthcare from an “underweight” rating to an “equal weight” rating and upped their price target for the company from $9.00 to $13.00 in a research report on Thursday, July 31st. KeyCorp upgraded shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price target for the company in a research report on Monday, August 25th. Wall Street Zen cut shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Sunday, August 10th. Finally, Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 29th. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Alignment Healthcare currently has an average rating of “Moderate Buy” and an average target price of $18.83.

Institutional Investors Weigh In On Alignment Healthcare

Institutional investors have recently modified their holdings of the company. MCF Advisors LLC boosted its stake in Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock worth $40,000 after acquiring an additional 1,011 shares in the last quarter. Skandinaviska Enskilda Banken AB publ bought a new position in Alignment Healthcare during the first quarter worth $42,000. SBI Securities Co. Ltd. boosted its stake in Alignment Healthcare by 4,868.9% during the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after acquiring an additional 2,970 shares in the last quarter. KBC Group NV bought a new position in Alignment Healthcare during the second quarter worth $44,000. Finally, Signaturefd LLC boosted its stake in Alignment Healthcare by 142.6% during the second quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock worth $53,000 after acquiring an additional 2,215 shares in the last quarter. 86.19% of the stock is owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.